TAG:
ehi
Success Seems Elusive To Pathology Innovators
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Attempts to organize pathology practice management companies encounter resistance and market impediments. Success requires an astute business plan and a sophisticated management team to convince pathologists to abandon proven practice models and affiliate with regional or nat…
Where’s The Write-down ? LabCorp Faces Key Decision
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Commercial laboratories are recognizing declines in the market value of their assets. LabCorp has yet to do the same. Taken cumulatively, these write-downs demonstrate the sizable revenue erosion that large commercial laboratories experienced during the past three years. Soon…
LabCorp Struggling To Regain Financial, Operational Balance
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: 1997 will be a “make or break” year for Laboratory Corporation of America. The company is challenged on many fronts. As LabCorp’s management focuses on internal issues, nimble laboratory competitors have an opportunity to capture additional market share. …
Las Vegas Lab Gathering Debates Industry Trends
By Robert Michel | From the Volume IV No. 4 – March 10, 1997 Issue
CEO SUMMARY: Always a good forum for discussion of laboratory industry trends, this year’s meeting in Las Vegas addressed government regulation, laboratory automation and everything in between. Here is a brief rundown on some of the more interesting insights and observations….
“February 17, 1997 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IV No. 3 – February 17, 1997 Issue
Meris Laboratories of San Jose, California settled government claims of Medicare and MediCal fraud with an agreement to pay $5.2 million. The announcement, on February 12, closes another whistleblower suit. MORE ON: Meris Labs… Besides the cholesterol and serum iron tests…
AmeriPath’s Strategies For Business Success
By Robert Michel | From the Volume IV No. 2 – January 27, 1997 Issue
CEO SUMMARY: Two fascinating aspects about the AmeriPath story are: 1) the strategy to boost share values; and 2) the strategy to develop profitable pathology revenues. With managed healthcare transforming pathology at an astounding rate, will AmeriPath succeed in both strategies?…
Three Public Laboratories Choose New Presidents
By Robert Michel | From the Volume IV No. 2 – January 27, 1997 Issue
CEO SUMMARY: Three public laboratories experiencing serious financial pressure enter the new year with a change in presidents. It is a sign that stockholders and creditors are growing increasingly restless with these organizations’ inability to earn satisfactory profits. …
CURRENT ISSUE

Volume XXXII, No. 7 – May 12, 2025
Economic, Tech changes drive lab concerns, The Dark Report provides insights from the Executive War College speakers about how clinical labs can use business strategies and tactics to handle the new tariffs, future regulations, and artificial intelligence (AI). Also, this issue provides guidance on how labs and pathologists should prepare for payer audits.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized